Tianjin Lisheng Pharmaceutical Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 655.49 million compared to CNY 612.1 million a year ago. Revenue was CNY 657.49 million compared to CNY 614.74 million a year ago.

Net income was CNY 90.18 million compared to CNY 71.95 million a year ago. Basic earnings per share from continuing operations was CNY 0.49 compared to CNY 0.39 a year ago. Diluted earnings per share from continuing operations was CNY 0.49 compared to CNY 0.39 a year ago.